Diseases [C] » Wounds and Injuries
Description
Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity. MeSH
Hierarchy View
Subtype Terms (53)
Abdominal Injuries
34 drugs (22 approved, 12 experimental)
Accidental Injuries
1 approved drug
Amputation, Traumatic
6 drugs (5 approved, 1 experimental)
Arm Injuries
13 drugs (11 approved, 2 experimental)
Asphyxia
11 drugs (9 approved, 2 experimental)
Athletic Injuries
11 drugs (7 approved, 4 experimental)
Back Injuries
8 drugs (6 approved, 2 experimental)
Barotrauma
2 approved drugs
Birth Injuries
2 drugs (1 approved, 1 experimental)
Bites and Stings
13 drugs (11 approved, 2 experimental)
Burns
197 drugs (117 approved, 80 experimental)
Cold Injury
5 drugs (3 approved, 2 experimental)
Crush Injuries
1 experimental drug
Drowning
1 experimental drug
Extravasation of Diagnostic and Therapeutic Materials
4 approved drugs
Fractures, Bone
126 drugs (92 approved, 34 experimental)
Hand Injuries
41 drugs (35 approved, 6 experimental)
Heat Stress Disorders
3 approved drugs
Hip Injuries
24 drugs (21 approved, 3 experimental)
Joint Dislocations
5 approved drugs
Lacerations
15 approved drugs
Leg Injuries
16 drugs (14 approved, 2 experimental)
Multiple Trauma
26 drugs (23 approved, 3 experimental)
Nasal Septal Perforation
11 drugs (8 approved, 3 experimental)
Radiation Injuries
7 drugs (6 approved, 1 experimental)
Rupture
4 approved drugs
Self Mutilation
1 approved drug
Shock, Traumatic
8 drugs (4 approved, 4 experimental)
Shoulder Injuries
41 drugs (30 approved, 11 experimental)
Soft Tissue Injuries
35 drugs (19 approved, 16 experimental)
Spinal Cord Injuries
196 drugs (103 approved, 93 experimental)
Sprains and Strains
84 drugs (47 approved, 37 experimental)
Surgical Wound
23 drugs (15 approved, 8 experimental)
Tendon Injuries
27 drugs (20 approved, 7 experimental)
Thoracic Injuries
10 drugs (8 approved, 2 experimental)
Tooth Injuries
1 experimental drug
Trauma, Nervous System
5 approved drugs
Tympanic Membrane Perforation
8 drugs (1 approved, 7 experimental)
Vascular System Injuries
6 drugs (1 approved, 5 experimental)
Wounds, Nonpenetrating
3 approved drugs
Wounds, Penetrating
2 approved drugs
Approved Indicated Drugs (19)
Phase 4 Indicated Drugs (52)
Phase 3 Indicated Drugs (27)
Phase 2 Indicated Drugs (36)
Phase 1 Indicated Drugs (12)
Other Experimental Indicated Drugs (38)
Organization Involved with Phase 4 Indications (209)
Ankara Yildirim Beyazıt University
Azienda Sanitaria dell'Alto Adige
Canadian Department of National Defense
Canadian Forces Health Services Group
Centre Hospitalier Saint Joseph Saint Luc de Lyon
Centro Universitario Ciencias de la Salud
Clinica Universidad de Navarra
Hoosier Cancer Research Network
Hospital Nacional de Paraplejicos
Hospital Nacional de Parapléjicos de Toledo
Icahn School of Medicine at Mount Sinai
Institute of Mountain Emergency Medicine
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Kahramanmaras Sutcu Imam University
Kessler Institute for Rehabilitation
Manitoba Medical Service Foundation
Misr University for Science and Technology
National Autonomous University of Mexico
National Center for Research Resources (NCRR)
National Institutes of Health (NIH)
National University of Malaysia
Norwegian University of Science and Technology
Ontario Mental Health Foundation
People's Liberation Army of China
Saint Joseph Saint Luc Hospital
Shahid Beheshti University of Medical Sciences
Sunnaas Rehabilitation Hospital
Taipei Veteran General hospital
Technical University of Dresden
The Craig H. Neilsen Foundation
The First People's Hospital of Lianyungang
Universidad Autonoma de Barcelona
Universitat Internacional de Catalunya
University of British Columbia
University of California, Davis
University of California, San Francisco
University of Colorado, Denver
University of North Carolina at Chapel Hill
University of Texas at Houston
University of Texas, Galveston
Virginia Commonwealth University
Washington University in St. Louis
ZonMw: The Netherlands Organisation for Health Research and Development
Organization Involved with Phase 3 Indications (161)
Assistance Publique - Hôpitaux de Paris
Australian and New Zealand Intensive Care Society Clinical Trials Group
Autonomous University of Madrid
Canadian Institutes of Health Research (CIHR)
Centre Hospitalier Universitaire de Nīmes
Christopher Reeve Paralysis Foundation
Daewon Pharmaceutical Co., Ltd.
Defence Research and Development Canada
Department of Health and Human Services
Health Research Board, Ireland
Health Research Council, New Zealand
Heart and Stroke Foundation of Canada
Henan University of Traditional Chinese Medicine
Institut d'Anesthesiologie des Alpes Maritimes
Institut National de la Santé Et de la Recherche Médicale, France
Instituto Mexicano del Seguro Social
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Irish Critical Care Clinical Trials Network
JP Moulton Charitable Foundation
Laboratorio Brasileiro de Biologia
Liaoning Hospital of Traditional Chinese Medicine
Major Extremity Trauma Research Consortium
Medical Developments International Limited
Medical Research Future Fund (MRFF)
Miami Cardiac and Vascular Institute
Moss Rehabilitation Research Institute
National Health and Medical Research Council, Australia
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Drug Abuse (NIDA)
National University of Ireland
Neurological Emergencies Treatment Trials Network
Ontario Neurotrauma Foundation
Pediatric Emergency Care Applied Research Network
Pharmaceutical Research Associates, Inc. (PRA)
Queen Elizabeth Hospital NHS Foundation Trust
Royal Hobart Hospital, TAS, Australia
Royal Marsden Hospital NHS Trust
Shriners Hospitals for Children
Organization Involved with Phase 2 Indications (215)
Acute Respiratory Distress Syndrome Foundation
American Association of Neurological Surgeons
American Society for Parenteral and Enteral Nutrition
Apeptico Forschung und Entwicklung GmbH
Beijing Tide Pharmaceutical Co., Ltd
Belarusian State Medical University
Center for Neurological Studies (CNS)
Children's Surgical Center, Cambodia
China Rehabilitation Research Center
China Spinal Cord Injury Network
Chinese Academy of Medical Sciences
Chinese University of Hong Kong
Cohen Children's Medical Center of New York
Community Medical Center, Scranton, PA
Eastern Association for the Surgery of Trauma
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
German Federal Ministry of Education and Research
Hospital Universitari Son Dureta
Huazhong University of Science and Technology
Human Stem Cell Institute, Russia
Indian Council of Medical Research
Instituto Nacional de Cardiologia Ignacio Chavez
Ivy Institute of Stem Cells Co. Ltd
Katholieke Universiteit Leuven
Koordinierungszentren für Klinische Studien bzw. Zentren für klinische Studien
Lieber Institute for Brain Development (LIBD)
Mashhad University of Medical Sciences
Memorial Hermann Health System
Midwestern Regional Medical Center
National Academy of Sciences of Belarus
National Cancer Institute (NCI)
National Institute for Health Research, United Kingdom
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Nursing Research (NINR)
Neuren Pharmaceuticals Limited
Neurogen Brain and Spine Institute
NeuroHealing Pharmaceuticals Inc.
Nordic Life Science Pipeline Inc.
Northern Ireland Clinical Trials Unit
North Florida Foundation for Research and Education
Oregon Health and Science University
Paralyzed Veterans of America Research Foundation
Rehabilitation Hospital of Indiana
Russian Academy of Medical Sciences
Sclnow Biotechnology Co., Ltd.
St. John Providence Health System
The Intensive Care Society United Kingdom
Translational Research Informatics Center, Kobe, Hyogo, Japan
Trident Clinical Research Pty Ltd
Uniformed Services University of the Health Sciences
University Hospital Quirón Dexeus, Barcelona
University of Illinois at Chicago
University of Southern California
Waisenmedizin e. V. Promoting Access to Essential Medicine
Organization Involved with Phase 1 Indications (49)
Children's Medical Center Dallas
Coalition to Support America's Heroes
King Edward Medical University
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Dental and Craniofacial Research (NIDCR)
Organization Involved with Other Experimental Indications (68)
Hamilton Health Sciences Corporation
Hormozgan University of Medical Sciences
I.M. Sechenov First Moscow State Medical University
Institute of Liver and Biliary Sciences, India
Instituto Nacional de la Nutrición Salvador Zubiran
Jacksonville Center for Clinical Research
Mary Free Bed Rehabilitation Hospital
Northern State Medical University
Ospedale Misericordia e Dolce, Prato
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.